Startup Deep Dive : Wow Skin Science — the D2C beauty brand that raised $98 million then shrank for three years

In the financial year to March 2022, a Bengaluru direct-to-consumer beauty brand grew its revenue 3.4 times to roughly ₹340 crore, one of the fastest scale-ups India’s beauty and personal care market had produced. Three years later that same brand reported revenue of ₹148.5 crore, less than half its peak, having shrunk in FY23, FY24 and FY25 in a row. This is WOW Skin Science, a brand that raised close to $98 million from ChrysCapital and Singapore’s GIC and then spent the next three years going into reverse.

The contradiction is the point of the story. WOW proved that an Indian founder could build a nationally recognised beauty label from a laptop and a performance-marketing budget faster than any legacy FMCG company would have believed possible. It also showed how quickly a brand built on paid acquisition can unravel when the money that bought that growth is switched off. What follows is the record, from audited filings and reputable reporting, of both halves of that arc.

Quick facts

What they do

WOW Skin Science sells mass-premium beauty and personal care products directly to consumers, mostly online. Its catalogue runs from apple cider vinegar and onion shampoos to vitamin C serums, face washes, body lotions and nutrition supplements, priced to undercut both imported labels and legacy FMCG. The parent group runs four brands – WOW Skin Science as the flagship, plus WOW Life Science, Body Cupid and Nature Derma – spanning more than 500 SKUs across skin, hair, bath and body, and nutrition. The business model was digital-first from launch: build demand through social media and performance marketing, sell through its own website and app and through marketplaces, and only later push into physical retail.

The origin

WOW was not the founders’ first attempt at business, and that matters to the story. Brothers Manish and Karan Chowdhary, together with Ashwin and Arvind Sokke, incorporated Fit & Glow Healthcare Private Limited in Bengaluru on 4 September 2014. Manish had previously run a retail electronics venture that, by his own account, lost around $1 million on unsold inventory and had to be shut down. That failure shaped the next company’s design: keep inventory light, sell direct, and let data decide what to make.

The company began as a dietary supplements brand, but the founders noticed that customers were buying its apple cider vinegar not to drink but to use on their hair and skin. They followed the data into personal care. The breakout product, an apple cider vinegar shampoo, launched at roughly ₹399 against a large competitor selling a 200ml bottle at about ₹1,299, as recounted to YourStory. The pitch was simple: trend-led ingredients – apple cider vinegar, onion, vitamin C – at a fraction of the incumbent price, marketed hard online. It was a formula built for the smartphone-and-UPI decade rather than the kirana shelf.

The struggle years

The early years were a grind rather than a rocket. From a small base, revenue at the reporting entity was only about ₹6.4 crore in FY20 before the D2C wave lifted it. The harder struggles came later and were largely of the growth-at-any-cost variety. As the brand scaled, marketing became the engine and the anchor at the same time: winning a customer online cost money, and holding attention against a wave of copycat ingredient brands cost more.

Two documented setbacks frame the difficulty:

• The FY23 reversal: after peaking near ₹340 crore in FY22, operating revenue fell to ₹258.1 crore in FY23 – a drop of about 24% – while net loss ballooned to ₹213.2 crore, per the ROC filing reported by Inc42 and Entrackr. The company was spending far more than it earned to defend a shrinking top line.
• The missed targets: in November 2022 the company told Indian Retailer it was targeting ₹550–600 crore of revenue in FY23 and ₹2,000 crore within 18–24 months. FY23 actually came in at ₹258.1 crore, and revenue has fallen every year since. The gap between the plan and the filing is the clearest measure of how the market turned against paid-growth D2C after 2022.

The turning point

The turning point was not a single triumphant launch but a deliberate reversal of strategy after FY23, when the founders chose survival over scale. On one side of the line sat FY23: revenue of ₹258.1 crore, advertising and promotion spend of ₹199.3 crore – equal to about 77% of operating revenue – and a net loss of ₹213.2 crore. That is a business buying its own sales. On the other side sat FY24: management cut advertising and promotion by 46% to ₹107 crore, trimmed total expenses by 22% to ₹377 crore, and narrowed the net loss to ₹130.2 crore, even as revenue slipped a further 10% to ₹233.5 crore. The trade was explicit: accept a smaller, shrinking top line in exchange for a smaller cash burn, and aim for profitability rather than headlines. Management publicly targeted near break-even by the fourth quarter of FY25. Whether the brand can stabilise revenue while it does so is the open question the numbers below leave hanging.

The money behind it

WOW raised comparatively little institutional capital for its profile – close to $98 million across two rounds – and much of it arrived at the top of the D2C cycle.

• ChrysCapital, April 2021 – about $50 million. The India-focused private equity firm took a minority stake, reported at around 35%, in a deal that mixed primary growth capital with a secondary sale by existing shareholders, valuing the company at roughly $125 million (Business Standard, YourStory). This was the round that turned a bootstrapped brand into a funded one.
• GIC of Singapore, June 2022 – $48 million (₹375 crore). The sovereign fund put in primary capital via compulsorily convertible debentures for a 17.24% fully diluted stake, at an estimated post-money valuation of $275–280 million (Entrackr, BusinessToday). This was the peak-valuation moment.
• The round that reportedly did not close. The company was later reported to be seeking $65–75 million at a targeted valuation of about $400 million (BW Disrupt). That valuation was a target described in reports, not a confirmed transaction, and no such round has been publicly confirmed.

The shape of the cap table matters: two institutional backers, both entering near the market’s high, and no mega-round to cushion the down years. That forced the discipline visible in the FY24 accounts.

How it makes money

WOW earns a gross margin on physical goods and then spends much of it acquiring the customer. The mechanics:

• Money in: product sales across its own website and app, third-party marketplaces (Amazon India as the primary volume driver, plus Flipkart and Nykaa), and, increasingly, offline retail.
• Cost of goods: raw material and manufacturing cost of goods was ₹94.2 crore in FY24, about 40% of revenue, down 23% year on year – a decent product margin before marketing.
• The expensive part: advertising and promotion, which ran at ₹199.3 crore in FY23 (about 77% of revenue) before being cut to ₹107 crore in FY24. This is where the model lives or dies; the take on each sale is thin once acquisition cost is counted.
• People: employee benefit expense actually rose 35% to ₹53.5 crore in FY24, even as other costs fell – consistent with building an offline and international team while cutting paid media.

The part people get wrong is assuming D2C means high margin. For WOW, the product margin is real but the customer-acquisition cost historically consumed most of it, which is why the company could grow revenue and lose money at the same time.

The numbers

Figures below are operating revenue and net loss as reported to the Registrar of Companies (FY21–FY24) under Body Cupid Private Limited, and Inc42’s data for FY25. Unit: ₹ crore. The first figure, FY24 revenue of ₹233.5 crore, is roughly $24.3 million at the reference rate below.

The pattern is unusual: revenue peaked in FY22, then fell for three consecutive years, while the loss peaked a year later in FY23 and has narrowed since. In plain terms, the company grew fast on borrowed momentum, over-spent to defend that growth, then pulled back spending faster than revenue could recover.

Where the money comes from

The revenue mix has shifted from pure online toward a wider distribution base. Company-stated figures given to Indian Retailer in November 2022 put the split at:

• Online, about 80% of sales at the time, of which the D2C website and app accounted for roughly 25–30% of total sales and marketplaces the rest.
• Offline, about 20% and rising, with a stated ambition to move toward a 60:40 online-to-offline split.
• Offline footprint: around 350 Beauty Advisor Stores with in-store representatives, presence in roughly 30,000 general-trade outlets, and modern-trade chains including Reliance, DMart and More.

The surprise is how central the offline pivot became to a brand that made its name as a digital-first label. Faced with rising online acquisition costs, WOW leaned into physical retail and international markets – its haircare has appeared on US retail shelves and marketplaces – precisely because the pure-online model that built it had become too expensive to keep feeding. Note that the channel percentages are company-stated from 2022 and have not been independently audited; treat them as direction, not precision.

The risks

• Revenue that keeps shrinking. Three consecutive years of decline, from ₹340.4 crore in FY22 to ₹148.5 crore in FY25, is the central risk. Cost cuts have narrowed the loss, but a brand cannot save its way to growth; if the top line keeps falling, break-even is a moving target.
• Dependence on paid acquisition. Advertising ran at about 77% of revenue in FY23. A model that needs to spend that heavily to sell has little pricing power and is exposed to every rise in digital ad costs. Cutting the spend, as WOW did in FY24, tends to shrink the top line with it.
• A crowded, low-moat category. Ingredient-led D2C beauty has fierce competition – Mamaearth’s parent Honasa Consumer (listed in 2023), Plum, mCaffeine and a long tail of copycats, alongside deep-pocketed legacy FMCG. Formulations are easy to imitate, so differentiation rests on brand and distribution rather than defensible technology.

The takeaway

The transferable lesson from WOW Skin Science is that growth bought with marketing is rented, not owned. The brand executed the D2C playbook almost perfectly on the way up – find a trend, price aggressively, market relentlessly, scale 3.4 times in a year – and then discovered that the same playbook, run in reverse, shrinks a business just as fast. When the founders finally chose margin over momentum after FY23, the loss narrowed but the revenue did not recover. For anyone building a consumer brand, the question WOW poses is uncomfortable and useful: if you switched off the ad spend tomorrow, how much of your business would still be there? That answer, not the growth rate, is the real measure of what has been built.

Frequently asked questions

Who owns WOW Skin Science?

The brand was founded in 2014 by brothers Manish and Karan Chowdhary with Ashwin and Arvind Sokke. Its reported financials are filed under Body Cupid Private Limited, a Bengaluru company. Institutional investors ChrysCapital (from April 2021) and GIC of Singapore (from June 2022) hold minority stakes.

What is the legal entity behind WOW Skin Science?

There are two entities in the story. The brand was launched under Fit & Glow Healthcare Private Limited, incorporated on 4 September 2014, which has since been renamed Vivayogi Private Limited. The revenue and loss figures reported by Inc42 and Entrackr are filed under Body Cupid Private Limited (CIN U52190KA2016PTC085256), which holds the WOW Skin Science trademark.

How much money has WOW Skin Science raised?

Close to $98 million across two institutional rounds: about $50 million from ChrysCapital in April 2021, valuing the company near $125 million, and $48 million (₹375 crore) from GIC in June 2022, at an estimated $275–280 million post-money valuation.

Why is WOW Skin Science’s revenue falling?

Revenue peaked near ₹340 crore in FY22 during the D2C boom and has declined every year since, to ₹148.5 crore in FY25. The main reason is a deliberate cut in advertising spend – from ₹199.3 crore in FY23 to ₹107 crore in FY24 – to reduce losses, which shrank the top line along with the burn.

Is WOW Skin Science profitable?

No. It reported a net loss of ₹130.2 crore in FY24 and about ₹117.8 crore in FY25 (Inc42 data). Losses have narrowed from the FY23 peak of ₹213.2 crore, and management has publicly targeted near break-even, but the company has not reported an annual profit.

Sources

Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).

• Entrackr – “Wow Skin revenue declines further in FY24; losses shrink by 24%” (November 2024)
• Inc42 – “WOW Skin Science Narrows Loss To INR 130 Cr, Revenue Dips 10% In FY24” (November 2024)
• Inc42 – WOW Skin Science company financials page, FY25 revenue and loss data (2026)
• Entrackr – “Wow Skin Science’s scale nears Rs 350 Cr in FY22, losses surged 15X” (December 2022)
• Entrackr – “Singapore’s GIC pumps $48 Mn in Wow Skin Science” (June 2022)
• Business Standard – “ChrysCapital invests $50 mn for minority stake in WOW Skin Science India” (April 2021)
• YourStory – “ChrysCapital invests $50M in D2C brand WOW Skin Science” (April 2021) and “From bankruptcy to bouncing back” founder profile
• BusinessToday – “WOW Skin Science raises primary capital from Singapore’s GIC” (May 2022)
• Indian Retailer – “Why WOW Skin Science is Betting Big on the Offline Retail Market” (November 2022)
• BW Disrupt – “Wow Skin Science Plans To Raise $65-75 Mn At $400 Mn Valuation” (report)
• Zauba Corp / Ministry of Corporate Affairs – entity records for Body Cupid Private Limited and Fit & Glow Healthcare Private Limited (now Vivayogi Private Limited)

Found an error? Write to us and we’ll correct it in the open, dated, on the piece.